Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14176 - 14200 of 14720 in total
Experimental
AMG-131 (T131), an orally-administered therapy, is expected to lower blood glucose in type II diabetic patients by improving the body’s ability to respond to insulin. T131 is a selective modulator of PPARg (peroxisome proliferator activated receptor gamma), a receptor involved in regulating the body’s ability to respond to insulin. T131...
Investigational
Matched Description: … is not structurally related to the thiazolidinedione class of PPARg agonists, which includes Actos and
CRx-139 is an oral synergistic combination drug candidates with novel mechanisms of action targeting multiple biological pathways simultaneously. It is a dissociated steroid designed to enhance the immuno-modulatory activity of a low-dose glucocorticoid steroid without a comparable increase in steroid-related side effects. The synergistic combination containing low doses of the...
Investigational
Matched Description: … The synergistic combination containing low doses of the glucocorticoid steroid prednisolone and the antidepressant …
Experimental
Netoglitazone (MCC-555) is a hypoglycemic agent.
Experimental
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
Investigational
An anticholesteremic agent.
Experimental
Talviraline has been used in trials studying the treatment of HIV Infections.
Investigational
Displaying drugs 14176 - 14200 of 14720 in total